Punam Malik is an Oncology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 217 publications with 6,844 citations (h-index 45); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3333 Burnet Ave. Ml 7015
Cincinnati, OH 452293026
Telephone
513-636-4266Registry record last updated 15 Jan 2015.
Clinical trials
- Screening Patients With Sickle Cell Disease for Kidney Damage
Sponsor: Children's Hospital Medical Center, Cincinnati
- Losartan to Reverse Sickle Nephropathy
Sponsor: Children's Hospital Medical Center, Cincinnati
- Trial of Zileuton CR in Children and Adults With Sickle Cell Disease
Sponsor: Children's Hospital Medical Center, Cincinnati
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Agios Pharmaceuticals, Inc.Program year20251 payment
- F. Hoffmann-La Roche AGProgram year20235 payments
- Novo Nordisk IncProgram year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
9 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
- Mechanisms underlying increased risk of hematological malignancy in sickle cell disease.
Cincinnati Childrens Hosp Med Ctr
FY2026$187,584R21CA299166 - Mechanisms underlying increased risk of hematological malignancy in sickle cell disease.
Cincinnati Childrens Hosp Med Ctr
FY2025$225,101R21CA299166 - Regulation of hematopoietic stem cell self-renewal by GTPase activating protein signaling
Cincinnati Childrens Hosp Med Ctr
FY2018$416,320R01DK102890
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Therapeutic strategies for sickle cell disease: towards a multi-agent approach
Nature Reviews Drug Discovery
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Rothenberg, MD
Cincinnati Children's Hospital Medical Center
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Stuart Goldstein, MD
Cincinnati Children's Hospital Medical Center
Andrew Redington
Cincinnati Children's Hospital Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”